MCM
MGNX icon

MAI Capital Management’s MacroGenics MGNX Stock Holding History

MAI Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,415
Closed -$12.8K – 3658
2026
Q1 		$12.8K Buy
+4,415
New +$9.42K ﹤0.01% 3033
2025
Q1 		– Sell
-140
Closed -$455 – 3520
2024
Q4 		$455 Buy
+140
New +$504 ﹤0.01% 3306

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

MAI Capital Management's MGNX Position: Q2 2026 in Review

MAI Capital Management sold out of MacroGenics (MGNX) in Q2 2026, closing a stake of 4,415 shares — an estimated $12.8K sold.

MAI Capital Management first reported a position in MGNX in Q4 2024 and held it in 2 quarters. The position peaked at $12.8K in Q1 2026. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • MAI Capital Management reported no remaining MacroGenics position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 4,415 MacroGenics shares in Q2 2026, an estimated $12.8K.
  • MAI Capital Management first reported a position in MacroGenics in Q4 2024 and held it in 2 quarters.
  • MAI Capital Management's MacroGenics position peaked at $12.8K in Q1 2026.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.